Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sultiam (N03AX03), nur Filmtabletten im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Olanzapin (N05AH03), ohne feste orale Darreichungsformen im Rahmen eines sogenannten Open-House-Modells
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (B03XA01) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Erythropoietin (ATC: B03XA01 - in der Wirkstärke bis 10.000 IE je Dosiereinheit)
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (L04AB06) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (L03AA02) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Bosutinib (L01EA04) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sulfasalazin (M01CX02) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Imiquimod (D06BB10) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Edoxaban (B01AF03) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ebastin (R06AX22) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Clobetasol (D07AD01) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Miglustat (ATC-Code nach WHO: A16AX06)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen exklusive der Darreichung Sirup (ATC-Code nach WHO: M01AE02)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-07 - Dapagliflozin
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: G04BX21)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-05 - Olanzapin embonat
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: C03XA01)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
GRA
ROSES 2025: A.10 INNOVATE
grants.gov
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to r...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: Amended, January 26, 2026. Sections 1 and 1.1 have been updated to encourage non-governmental organizations new to NASA to partner with NASA centers, and a requirement was added to Section 4 to plan for operation beyond the award period. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals (in Section 7) has been updated to refl...
GRA
ROSES25: B.2 Heliophysics Foundational Research
grants.gov
The close date above is the date ROSES25 closes. The Step-2 due date will be announced at least 60 days before the Step-2 proposal due date. The Step-...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
The close date above is the date ROSES25 closes. The Step-2 due date will be announced at least 60 days before the Step-2 proposal due date. The Step-1 proposal due date is May 1, 2026. Step-2 proposals cannot be submitted if a Step-1 proposal was not submitted. NOTICE: Amended February 11, 2026. This amendment makes two corrections to this program element: The length of the Step-1 Proposal in Section 3.3.1 has been corrected from two pages to three, and the expected budget numbers given in the summary table are per award, per year, not the budget for all of the new awards in the SST. NOTICE: Amended February 3, 2026. This amendment releases the final text for this program element, which was previously TBD. Step-1 proposals are due May 1, 2026. The Step-2 due date will be announced at least 60 days before the Step-2 proposal due date, see Section 3.1. An individual may be Principal Investigator (PI) of one and only one proposal to this program element. There is an exception for multipl...
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
37351
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sultiam (N03AX03), nur Filmtabletten im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37352
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Olanzapin (N05AH03), ohne feste orale Darreichungsformen im Rahmen eines sogenannten Open-House-ModellsBuyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37353
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (B03XA01) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (L04AB06) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37358
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (L03AA02) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37359
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Bosutinib (L01EA04) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37360
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sulfasalazin (M01CX02) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37361
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Imiquimod (D06BB10) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37362
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Edoxaban (B01AF03) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37363
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ebastin (R06AX22) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37364
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Clobetasol (D07AD01) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37365
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Miglustat (ATC-Code nach WHO: A16AX06)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37366
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen exklusive der Darreichung Sirup (ATC-Code nach WHO: M01AE02)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37367
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-07 - DapagliflozinBuyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: G04BX21)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37371
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-05 - Olanzapin embonatBuyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: C03XA01)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
37374
ROSES 2025: A.10 INNOVATEThis program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: Amended, January 26, 2026. Sections 1 and 1.1 have been updated to encourage non-governmental organizations new to NASA to partner with NASA centers, and a requirement was added to Section 4 to plan for operation beyond the award period. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals (in Section 7) has been updated to reflect that ROSES-25 will be open until August 2026. Proposals may be submitted at any time until August 31, 2026. New text is in bold and deleted text is struck through. NOTICE: Amended September 22, 2025. This amendment announces that those proposing to Earth Science (ROSES Appendix A) to use the NASA Center for Climate Simulation high-end computing facility must include $0.09/SBU in their budget per the instructions provided in Section 7.3 of ROSES-25 A.1 Earth Science Research Overview. This applies to all open and future program elements in Appendix A (Earth Science) as of 09/22/2025. This....
37375
ROSES25: B.2 Heliophysics Foundational ResearchThe close date above is the date ROSES25 closes. The Step-2 due date will be announced at least 60 days before the Step-2 proposal...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
The close date above is the date ROSES25 closes. The Step-2 due date will be announced at least 60 days before the Step-2 proposal due date. The Step-1 proposal due date is May 1, 2026. Step-2 proposals cannot be submitted if a Step-1 proposal was not submitted. NOTICE: Amended February 11, 2026. This amendment makes two corrections to this program element: The length of the Step-1 Proposal in Section 3.3.1 has been corrected from two pages to three, and the expected budget numbers given in the summary table are per award, per year, not the budget for all of the new awards in the SST. NOTICE: Amended February 3, 2026. This amendment releases the final text for this program element, which was previously TBD. Step-1 proposals are due May 1, 2026. The Step-2 due date will be announced at least 60 days before the Step-2 proposal due date, see Section 3.1. An individual may be Principal Investigator (PI) of one and only one proposal to this program element. There is an exception for multiple submissions per PI only when institutions require oversight for efforts that involve Science PIs. The rules regarding interagency awards described in Section 1.1.1 of B.1 Heliophysics Research Program Overview and Section 7 apply to this program element. Proposals submitted to this program will be evaluated using a dual-anonymous review process. Proposals must be prepared according to the guidelines in Section 2.4.2 and in the associated "Guidelines for Proposers to ROSES DAPR Programs" document under "Other Documents" on the NSPIRES page for this program element. All proposers are strongl...
No saved opportunities on this page. Use the star icon near an opportunity title.
